$1.98
▼ -1.5% Today
as of Oct 23, 09:16 ET
Last 30 days
Recent Press Releases & News
Elite Pharmaceuticals vs. Aytu: Which CNS Stock Is the Better Buy?
Aytu BioPharma, Inc. Q4 2026 Earnings Call Summary
Aytu BioPharma Inc (AYTU) (Q4 2026) Earnings Call Highlights: EXXUA Launch Accelerates as ...
AYTU earnings at a glance
Over its last 2 reports the stock rose the next day 1 time and fell 1, moving ±2.6% on average; after the most recent report on May 13, 2026 it moved -2.2%. AYTU beat the consensus EPS estimate in 0 of its last 3 reported quarters. The share price of $1.98 sits near its 52-week low.
Overview
52-week range
$1.80
$3.07
14% of range
Avg surprise (last 3)
-434.8%
Avg reaction (last 2)
+0.4%
50% positive
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Wed May 13, 2026 | Mar/2026 | $-0.53 | $-0.31 | -71.0% | -365.0% | -2.2% | earnings |
| Wed Dec 31, 2025 | Dec 2025 | $-1.05 | — | — | — | — | financials |
| Thu Nov 13, 2025 | Sep/2025 | $-0.08 | $-0.06 | -33.3% | — | — | earnings |
| Tue Sep 23, 2025 | Jun/2025 | $-0.26 | $-0.02 | -1,200% | — | — | earnings |
| Wed May 14, 2025 | Mar/2025 | $0.20 | — | — | — | +3.1% | earnings |
| Tue Dec 31, 2024 | Dec 2024 | $-0.26 | — | — | — | — | financials |
| Mon Sep 30, 2024 | Sep 2024 | $-0.15 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.52 | — | — | — | — | financials |
| Sun Dec 31, 2023 | Dec 2023 | $-0.04 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-1.48 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $-1.93 | — | — | — | — | financials |
| Sat Dec 31, 2022 | Dec 2022 | $-2.15 | — | — | — | — | financials |
| Fri Sep 30, 2022 | Sep 2022 | $-0.28 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $12M | $15M | $14M | — | $18M | $16M | $17M | — |
| Cost of revenue | $5M | $6M | $5M | — | $6M | $5M | $5M | — |
| Gross profit | $8M | $10M | $9M | — | $13M | $11M | $12M | — |
| Operating income | $-4M | $-2M | $-2M | — | $2M | $-2M | $-930,000 | — |
| Net income | $-6M | $-11M | $2M | — | $4M | $788,000 | $1M | — |
| EPS (diluted) | $-0.53 | $-1.05 | $-0.08 | — | $0.21 | $-0.26 | $-0.15 | — |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $27M | $30M | $33M | $31M | $18M | $20M | $20M | $20M |
| Inventory | $7M | $9M | $10M | $11M | $11M | $11M | $12M | $12M |
| Total current assets | $67M | $76M | $81M | $79M | $73M | — | — | $62M |
| Total assets | $112M | $122M | $125M | $124M | $124M | $116M | $116M | $118M |
| Long-term debt | $10M | $10M | $10M | — | $10M | $10M | $10M | $11M |
| Total liabilities | — | — | — | — | — | — | — | — |
| Total equity | $35M | $14M | $23M | $19M | $35M | $31M | $30M | $28M |
Implied volatility — last 90 days
No IV snapshots yet for AYTU.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.
Sector peers
AYTU earnings FAQ
How does AYTU stock usually react to earnings?
Across the last 2 reports the average next-day move was ±2.6%, up 1 times and down 1 times.